If you are:
Only When Necessary: SYSTEMIC ABSORPTION UNKNOWN; POSSIBLE RISK OF OROFACIAL CLEFTS WITH SYSTEMIC USE
FDB Contraindicated or Not Recommended: LIMITED DATA SUG ADV EFFECTS WITH EXPOSURE TO TOPICAL SALICYLATES
No Known Risk: INSUFFICIENT DATA AVAILABLE; LIMITED USE MAY POSE LITTLE RISK
Precaution: INSUFFICIENT DATA AVAILABLE. NOT RECOMMENDED BY MFR
An adult over 60:
management or monitoring precaution: Risk for possible acute inflammation or ulceration of the extremities particularly in those patients with decreased circulation to the extremities for any reason.
Giving Scalp Relief Solution, Non- to a child under 12:
management or monitoring precaution: Prolonged or extensive use may lead to systemic absorption; may affect growth rate.
management or monitoring precaution: Prolonged use or use on extensive skin areas may lead to systemic toxicity, e.g. hemostatic or metabolic changes.